Latest Insider Transactions at Codiak Bio Sciences, Inc. (CDAK)
This section provides a real-time view of insider transactions for Codiak Bio Sciences, Inc. (CDAK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Codiak BioSciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Codiak BioSciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 20
2022
|
Nicole Barna |
BUY
Open market or private purchase
|
Direct |
6,781
+50.0%
|
$47,467
$7.37 P/Share
|
|
Aug 09
2021
|
Sriram Sathyanarayanan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,300
-78.88%
|
$27,300
$21.55 P/Share
|
|
Aug 09
2021
|
Sriram Sathyanarayanan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+50.0%
|
$3,900
$3.29 P/Share
|
|
Aug 06
2021
|
Sriram Sathyanarayanan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,300
-100.0%
|
$26,000
$20.16 P/Share
|
|
Aug 06
2021
|
Sriram Sathyanarayanan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+50.0%
|
$3,900
$3.29 P/Share
|
|
Jun 08
2021
|
Benny Sorensen Officer |
SELL
Open market or private sale
|
Direct |
8,533
-90.39%
|
$213,325
$25.82 P/Share
|
|
Jun 08
2021
|
Benny Sorensen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,533
+50.0%
|
$25,599
$3.29 P/Share
|
|
Jun 08
2021
|
Konstantin Konstantinov Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
7,276
-93.1%
|
$181,900
$25.79 P/Share
|
|
Jun 08
2021
|
Konstantin Konstantinov Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,276
+50.0%
|
$21,828
$3.29 P/Share
|
|
Feb 17
2021
|
Briggs Morrison Director |
BUY
Open market or private purchase
|
Direct |
4,761
+50.0%
|
$99,981
$21.0 P/Share
|
|
Oct 16
2020
|
Alaska Permanent Fund Corp |
BUY
Open market or private purchase
|
Indirect |
235,000
+4.95%
|
$3,525,000
$15.0 P/Share
|
|
Oct 16
2020
|
Alaska Permanent Fund Corp |
BUY
Conversion of derivative security
|
Indirect |
4,213,932
+13.69%
|
-
|
|
Oct 16
2020
|
Steven Gillis Director |
BUY
Open market or private purchase
|
Indirect |
235,000
+8.58%
|
$3,525,000
$15.0 P/Share
|
|
Oct 16
2020
|
Steven Gillis Director |
BUY
Conversion of derivative security
|
Indirect |
2,204,940
+32.38%
|
-
|
|
Oct 16
2020
|
Douglas E Williams President & CEO |
BUY
Conversion of derivative security
|
Direct |
9,585
+50.0%
|
-
|
|
Oct 16
2020
|
Arch Venture Fund Viii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
235,000
+8.58%
|
$3,525,000
$15.0 P/Share
|
|
Oct 16
2020
|
Arch Venture Fund Viii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,555,135
+29.84%
|
-
|
|
Oct 16
2020
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
165,000
+12.61%
|
$2,475,000
$15.0 P/Share
|
|
Oct 16
2020
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,956,354
+28.89%
|
-
|
|
Oct 13
2020
|
Kyriazi Theo Melas Director |
BUY
Open market or private purchase
|
Direct |
6,600
+50.0%
|
$99,000
$15.0 P/Share
|